![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 24, 18297-18301, June 16, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, March 8, 2000
The in vivo role of epidermal growth
factor (EGF) is not well defined even though its effects on culture
cells were well studied. To understand the developmental,
physiological, and pathological roles of EGF, we have generated
transgenic mice widely expressing human EGF with the use of the
Epidermal growth factor
(EGF)1 was identified by
Cohen (1) in the 1960s. Surprisingly, injection of crude salivary gland extract into newborn mice induced precocious eyelid opening and incisor
eruption. Mature EGF purified from mouse salivary gland is composed of
53 amino acids but is derived from a much larger transmembrane
precursor of 1217 amino acids (2, 3). The physiological role of EGF in
reproduction is suggested by various studies on the effects of
sialoadenectomy (removal of salivary gland), which depleted circulating
EGF. In male mice, the production of EGF in submandibular gland
increases until sexual maturation (4). Studies showed that after
sialoadenectomy, serum testosterone either remained unchanged in adults
(5) or increased in peripubertal mice (6). Nevertheless, both studies
reported reduced sperm count, which returned to normal with EGF
replacement. So, EGF deficiency was linked to some unexplained cases of
male infertility, in particular oligospermia.
Transforming growth factor We have recently reported that both full-length and a shortened form of
human EGF precursor (hEGF) was biologically active in transforming NIH
3T3 cells (13). Because little is known about the in vivo
role of EGF, we generated transgenic mice widely expressing hEGF in the
present study. The Animals--
Mice were held in the Laboratory Animal Unit of the
University of Hong Kong. F1 hybrid mice were routinely raised from
breeding pairs of C57BL/6N female × CBA/N male. All mice were
maintained on a 12-h light and 12-h dark cycle. Autoclaved food
(Purina) and UV-irradiated water were available ad libitum.
Principles of laboratory animal care and specific national laws
relating to the welfare of animals were followed. Research protocols
were approved by an institutional ethics committee.
Construction of Generation of Transgenic Mice--
DNA was introduced at a
concentration of 5 ng/µl into F1 and FVB/N embryos by standard
microinjection procedures (15, 16). At weaning of the resulting pups,
DNA from tail biosies were screened by polymerase chain reaction with
primers 5'-AGTGACTCTGAATGTCCCC and 5'-GTTGCATTGACCCATCTGCTG, which were
specific for human EGF. The temperature profile was denaturation at
94 °C for 3 min, followed by 29 cycles of 94 °C for 45 s,
55 °C for 30 s, and 72 °C for 30 s.
Tissue Preparation and Western Blot--
Mice were sacrificed by
cervical dislocation, and organs were collected immediately for
histology or protein preparation. For Western analysis, membrane
proteins were prepared according to Ref. 17. Samples (60 µg as
determined with a Coomassie Blue dye binding assay; Bio-Rad) were
separated in a 8% polyacrylamide gel and transferred to a Hybon-ECL
membrane (Amersham Pharmacia Biotech). Human EGF was detected using
polyclonal antibody Ab-3 (Calbiochem), which recognized human but not
mouse EGF, at 1:500 and secondary antibody (Amersham Pharmacia Biotech)
at 1:1000 as described in our previous work (13).
Immunohistochemistry--
The histology and immunohistochemical
methods used were as described previously (18). In brief, freshly
collected tissues were fixed overnight in 4% paraformaldehyde at
4 °C. The sections were treated with 3% hydrogen peroxide for 30 min to inactivate the endogenous peroxidase and washed thoroughly with
distilled water and then Tris-buffered saline, pH 7.4. After incubation with 10% normal goat serum, the primary antibody Ab-3 was applied for
2 h at room temperature. Then the sections were washed with Tris-buffered saline and incubated with streptavidin-biotinylated peroxidase complex (Dako) for 30 min. The sections were then washed with Tris-buffered saline and incubated with 1 mg/ml of
3,3'-diaminobenzidine tetrahydrochloride chromogen solution (Dako) with
0.02% of hydrogen peroxide for 5 min. After counterstaining with
hematoxylin, the sections were dehydrated with graded alcohol and
xylene and mounted with Permount. Sections were inspected using
ordinary light microscopy.
Serum Testosterone Levels--
Blood was collected by cardiac
puncture immediately after the animal was killed by cervical
dislocation. Blood samples were kept on ice for 15 min, followed by
centrifugation at ~6,000 × g. The supernatant was
aliquoted and stored at Construction of DNA Microinjection Fragment--
Initially, we
tried using the phosphoglycerate kinase-1 promoter to drive both hEGF
expression and the reporter gene Generation of Transgenic Mice Expressing hEGF--
Five transgenic
mice, named T1-T5, were generated independently. T2, T3, and T4 were
FVB males from the same litter. T1 and T5 were F1 females from separate
litters. Immunoblot showed that hEGF, with the expected size of 40 kDa,
was highly expressed in the membrane fraction of all tissues tested,
including submandibular gland, kidney, liver, and testis (Fig.
1C). This demonstrates that hEGF protein was widely and
highly expressed under the Retarded Growth of hEGF Transgenic Mice--
All five transgenic
animals were found to be smaller than nontransgenic littermate(s), and
the reduction in size appeared proportionate. A significant difference
in body weight was already apparent in both sexes since birth (Fig.
2A). At adulthood they attained 70% of the weight of nontransgenic littermates (Fig. 2B).
Immunohistochemical Staining of Submandibular Gland and Testis of
Transgenic Mice--
Immunostaining of hEGF in the submandibular gland
and gonad was performed for all transgenic animals. They all showed
similar immunostaining. In submandibular gland, the whole organ
expressed hEGF (brown), with more prominent staining in granular tubule cells (Fig. 3A). In the testis
of T2-T4, immunostaining of testis revealed brown staining in all cell
types including germ cells, interstitial cells and Sertoli cells. No
staining was seen in nontransgenic littermates (Fig.
3B).
Developmental Abnormalities in Testis--
Two out of three
transgenic males (T3 and T4) never sired offspring till sacrifice at 9 months. T2, which was sacrificed at 2 months old, had 76 offspring from
10 litters but none of them were transgenic. This observation suggests
that he was mosaic and that little or no functional sperm was derived
from transgenic spermatogonia. For the sterile males, their testis
histology revealed similar features (Fig.
4). The tubules were of smaller diameter, but the tubular lumen was enlarged, which is typical of
hypospermatogenesis. The thickness of germ cell layers was uneven; some
region had just a layer of spermatogonia. Normally, spermatids at
particular stage(s) will be present in all tubular sections, but this
is not the case in T3 and T4. For them, very few tubular regions contained spermatids and spermatozoa. These post-meiotic II germ cells,
if present, were much less than normal. Only a small number of
spermatocytes went past the pachytene stage. No sperm was retrieved from epididymis of T3 and T4 in an attempt to collect capacitated sperms for in vitro fertilization and cryopreservation.
Infertility May Be Related to Low Serum Testosterone Level in Male
Transgenic Mice--
The mean serum testosterone for transgenic mice
(n = 3) was significantly lower than for age-matched
controls (n = 6) (16.623 ± 1.815 versus 81.715 ± 17.723 nmol/liter, p = 0.01). However, the sizes of seminal vesicles and prostate glands were
normal. T3 and T4 seemed to lack mating behavior. Vaginal plugs were
not found in females caged with T3 or T4.
We have generated hEGF transgenic mice that appeared to be
proportionate dwarfs. They were born with only half of the weight of
normal littermates. These findings coincide with previous reports that
injection of EGF induced growth retardation in newborn rats (19) and
inhibited adipose tissue development (8). Calamandrei and Alleva (20)
reported that EGF treatment retards both the rate of body growth and
the full appearance of several neurobehavioral signs of maturation.
Webber et al. (21) reported that transgenic mice
overexpressing TGF- The unexpected finding of the present report is male infertility with
EGF overexpression. The physiological role of EGF in reproduction is
suggested by various studies on the effects of depleting circulating
EGF by sialoadenectomy. Studies showed that after sialoadenectomy,
serum testosterone either remained unchanged in adult (5) or increased
in peripubertal mice (6). Both studies reported reduced spermatid count
that returned to normal with EGF treatment. In Ref. 5, there was
accumulation of pachytene spermatocytes, whereas in Ref. 6, a decrease
in preleptotene and pachytene spermatocytes was noted. This suggests a
relationship between EGF and spermatogenesis, especially at the stage
of meiosis II. That EGF deficiency is linked to oligospermia is further
shown in streptozotocin-induced diabetic mice. Both the reduction in sperm count and EGF level could be restored by insulin. These effects
were abolished by the concomitant administration of EGF antiserum (24).
In this report, we showed that EGF overexpression in testis, on the
other hand, again led to reduced spermatogenesis, especially in the
production of spermatids and spermatozoa. We therefore suggest that
proper dose of EGF is important for spermatogenesis, in particular for
progress from MI to MII of meiosis. It is interesting to note that
maturation arrest of germ cells causes 10-30% of male infertility in
humans (25). The most common is arrest at spermatocyte I, also called
meiotic I arrest. Similar to the case in our transgenic males, it is
characterized by absence or less than 10% of tubules containing cells
beyond the pachytene stage (26).
EGF, TGF This paper provides the first in vivo evidence that EGF
overexpression can adversely affect spermatogenesis. This contrasts the
previous report on overexpression of TGF Besides a primary defect in the germ cells, overexpression of EGF in
the somatic lineages of the testis may have a secondary effect on
spermatogenesis and fertility in our transgenic animals. A large volume
of in vitro data have shown the effects of EGF on the
proliferation and function of Sertoli and Leydig cells. We suggest that
reduced serum testosterone in the transgenic mice was due to either
direct effect of EGF on testosterone production by Leydig cells (33,
34) or indirect effect of EGF on gonadotrophin production.
Nevertheless, we propose that lower testosterone was unlikely to be
their underlying cause of infertility, because the serum testosterone
level in all three transgenic males were similar and T2 was fertile.
The male accessory glands, which are sensitive to serum testosterone
levels (35, 36), still developed to appropriate sizes in our transgenic
males. As a next step in delineating the functions of EGF in
spermatogenesis, overexpression in specific cell types, for example in
pachytene spermatocytes, will help to establish the autocrine/paracrine
role of EGF in spermatogenesis.
We thank Prof. G. I. Bell for providing
EGF cDNA, Prof. C. Y. Yeung for continuous support, Dr.
W. S. B. Yeung for serum hormone measurements and comments,
and Bobo Mok for discussion.
*
This work was supported by the Hong Kong Research Grants
Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Anatomy and Cell Biology, Graduate School
of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Published, JBC Papers in Press, March 22, 2000, DOI 10.1074/jbc.M001965200
The abbreviations used are:
EGF, epidermal
growth factor;
TGF, transforming growth factor;
hEGF, shortened form of
human EGF precursor.
Overexpression of Epidermal Growth Factor Induced
Hypospermatogenesis in Transgenic Mice*
§,
,
,
,
Paediatrics and
¶ Biochemistry, The University of Hong Kong, Queen Mary Hospital,
Hong Kong
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-actin promoter. EGF and transforming growth factor
(TGF
)
bind with equal affinity to the EGF receptor, a transmembrane tyrosine
kinase, to trigger various biological responses. EGF and TGF
signaling are implicated in the development of the reproductive system.
EGF also plays a physiological role in reproduction. Removal of the
salivary gland in rodents, which reduces circulating EGF, reduces
spermatogenesis, which can be corrected by EGF replacement. Here we
show that in our transgenic males, only few post-meiosis II gametes
were found, and the mice were sterile. This resembles a common cause of
infertility in humans. Furthermore, the transgenic males had reduced
serum testosterone. Our findings contrast the previous report on
transgenic mice overexpressing TGF
in testis, which showed normal
spermatogenesis. These data suggest that EGF is the active ligand for
EGF receptor reported in germ cells, and proper EGF expression is
important for completion of spermatogenesis.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(TGF
) is biologically and
structurally related to EGF. From the expression patterns of EGF, TGF
, and their common receptor, TGF
was suggested to act during early pubertal stages to support the active somatic cell growth in
testis. However, the role of TGF
in spermatogenesis is not evident
(7, 8). EGF is involved in differentiation of the male reproductive
system through modulation of androgen receptor activity (9). Various
in vitro studies also showed that EGF affects the functions
of Sertoli cells (10) and Leydig cells (11). Furthermore, expression of
EGF protein in specific cell types of the testis suggests that it may
act in a paracrine/autocrine fashion in spermatogenesis. Mature EGF was
found in Sertoli cells, pachytene spermatocytes, and round spermatids
in mice. In contrast, EGF precursor immunostaining was limited to
pachytene spermatocytes and round spermatids (12). The transcript (7)
and protein (8) for EGF receptor was identified specifically in all the above testicular cell types.
-actin promoter was used because it had been
shown to drive widespread transgene expression (14). The eight EGF-like
repeats in the EGF precursor were deleted to give hEGF, leaving the
active EGF domain in the transmembrane form. Transgenic males
expressing hEGF were sterile with hypospermatogenesis. This is in
contrast to transgenic mice overexpressing TGF
in the testis, which
were reported to have normal testis morphology and spermatogenesis (7).
Together with the expression studies described above, we suggest that
EGF instead of TGF
is likely to be the physiological ligand for EGF
receptor in spermatogenesis.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Actin Promoter hEGF Plasmid--
The
structure of full-length EGF precursor is given in Fig.
1A, and the construct for
microinjection is shown in Fig. 1B. The hEGF cDNA was
regulated by the
-actin promoter to give widespread expression in
transgenic animals. Construction of cDNA for hEGF has been
described (13). Briefly, the region encoding the 8 EGF-like repeats was
deleted by digestion with EcoRI (position 547, GenBankTM accession number X04571) and Bsu36I
(3313). The reading frame is conserved after religation of the end
filled sites as checked by sequencing. The resulting cDNA (1.06 kilobases) was ligated with the 4.3-kilobase
-actin promoter and the
0.3-kilobase SV40 poly(A) in pBluescript KS+ (Strategene). For
microinjection, insert DNA was released by digestion with
XbaI and SalI, purified using the QIAEX gel
extraction kit (Qiagen, Chatsworth, CA), and passed through a spin-X
column (Costar).

View larger version (39K):
[in a new window]
Fig. 1.
. Generation of transgenic mice overexpressing
hEGF. A, structure of the full-length EGF precursor.
B, DNA fragment for microinjection. The region encoding the
eight EGF-like repeats was deleted. C, a representative
result of Western blot analysis showing expression of hEGF. Lanes
T, T3; lanes C, a nontransgenic littermate;
SG, submandibular gland; Kid, kidney;
Liv, liver; Tes, testis.
20 °C until assay. Serum samples were
measured using a Coat-A-Count total testosterone kit from Diagnostic
Products Corp. Controls were age-matched FVB/N and F1 males.
Statistical differences between transgenic and control groups were
analyzed using the Mann-Whitney Test.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
geo with the use of
internal ribosomal entry site. The construct has been described before
(13). However, this construct was not giving high level of transgene
expression in transgenic mice. Under this condition we changed the
strategy and constructed the
-actin promoter injection plasmid (Fig.
1B).
-actin promoter.

View larger version (45K):
[in a new window]
Fig. 2.
Stunted growth in transgenic mice.
A, a pair of 6-day-old FVB mice showing visible difference
in size between the transgenic mice and its littermate. B,
postnatal growth curves of mice from the same litter. Wild type (
)
(n = 3) and transgenic mice (
) (n = 3).

View larger version (113K):
[in a new window]
Fig. 3.
Immunohistostaining studies.
A, submandibular gland sections with antibody Ab-3.
Detection of hEGF protein in submandibular gland of transgenic mice
(bottom panel) but not in control (top panel). In
transgenic mice, the whole organ expressed hEGF (brown),
with more prominent staining in granular tubule cells. No such deposits
were seen in nontransgenic mice. Scale bars, 50 µm.
B, immunohistostaining of testis sections with Ab-3. Brown
staining was found in all cells including interstitial cells, Sertoli
cells as well as germ cells of transgenic mice (bottom
panel). No such deposits were seen in nontransgenic mice
(top panel). Scale bars, 50 µm.

View larger version (123K):
[in a new window]
Fig. 4.
Hypospermatogenesis in transgenic mice.
Testis section of transgenic (A and B) and a wild
type littermate (C and D) at 9 months old stained
with hematoxylin and eosin. Transgenic tubules contained fewer germ
cells, in particular spermatids and spermatozoa. The germ cell layer in
a tubular cross section was uneven in thickness. Scale bars,
50µm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
weighed approximately 10% less than the
control. In a recent report, Dealy et al. (22) examined the
distribution of TGF-
, EGF, and the chicken EGF receptor (encoded by
c-erbB) in embryonic chick limbs. They found that exogenous TGF-
and EGF inhibited chondrogenesis and myogenesis of limb mesenchyme in vitro. They concluded that signaling through
the EGF receptor via endogenous TGF-
and EGF may be important for initial limb formation, outgrowth of limb mesoderm, and regulation of
limb chondrogenic and myogenic differentiation. More recently, Erwin
et al. (23) reported the effect of intestinal overexpression of EGF. A murine EGF precursor cDNA construct was produced, and expression of the transgene was targeted to the small intestine with
the use of rat intestinal fatty acid-binding protein promoter. Interestingly, their transgenic animals had improved post-resection adaptation. Besides shortened small intestine, no other abnormal phenotype was observed.
, and amphiregulin are known to bind and activate only the
EGF receptor (ErbB1) (27). That EGF is the endogenous ligand for EGF
receptor in spermatogenesis is supported by expression of EGF but not
TGF
protein in specific germ cell types of the testis. In adult
mice, EGF precursor immunostaining was limited to pachytene
spermatocytes and round spermatids, whereas mature EGF was found in
addition in Sertoli cells (12). The source of mature EGF in these cells
remained to be determined. EGF, but not TGF
, was also found in the
germ cells in boar. In addition, EGF receptor immunostaining varied
according to the course of spermatogenesis, with predominant EGF
receptor staining in pachytene spermatocytes before and during meiosis
and in post-meiotic germ cells (8). Bartlett et al. (28)
have also shown increased testicular EGF concentrations in synchronized
rat testes that were closed to the meiotic stages.
in a line of transgenic mice, which highly expressed human TGF
protein in testis and seminal
vesicle. These mice did not have abnormal testis morphology or
spermatogenesis (7), suggesting that the two growth factors may have
different roles in spermatogenesis. Interestingly, both reduction of
circulating EGF by sialoadenectomy and EGF overexpression result in
hypospermatogenesis. The expression patterns of EGF, TGF
, and their
common receptor in testis together with the physiological studies
mentioned above and the overexpression studies in transgenic mice all
agreed to the suggestion that the EGF-EGF receptor system is involved
in the meiotic process. Furthermore, the EGF receptor is shown to be
functional in spermatogonia and spermatozoa (29, 30). Although EGF
seems to be the physiological ligand in germ cell development, mice
with either single or triple null mutations in EGF, TGF
, and
amphiregulin did not suffer from reduced fertility (31). This raises
the possibility of functional redundancy with heparin-binding EGF,
betacellulin, and epiregulin, which bind ErbB4 as well as EGF receptor
(reviewed in Ref. 32).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.:
852-28554634; Fax: 852-28551523; E-mail: sychan@hkucc.hku.hk.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Cohen, S.
(1962)
J. Biol. Chem.
237,
1555-1562
2.
Gray, A.,
Dull, T. J.,
and Ullrich, A.
(1983)
Nature
303,
722-725
3.
Scott, J.,
Urdea, M.,
Quiroga, M.,
Sanchez-Pescador, R.,
Fong, N.,
Selby, M.,
Rutter, W. J.,
and Bell, G. I.
(1983)
Science
221,
236-240
4.
Byyny, R. L.,
Orth, D. N.,
and Cohen, S.
(1972)
Endocrinology
90,
1261-1266
5.
Tsutsumi, O.,
Kurachi, H.,
and Oka, T.
(1986)
Science
233,
975-977
6.
Liu, A.,
Flores, C.,
Kinkead, T.,
Carboni, A. A.,
Menon, M.,
and Seethalakshmi, L.
(1994)
J. Urol.
152,
554-561
7.
Mullaney, B. P.,
and Skinner, M. K.
(1992)
Mol. Endocrinol.
6,
2103-2113
8.
Caussanel, V.,
Tabone, E.,
Mauduit, C.,
Dacheux, F.,
and Benahmed, M.
(1996)
Mol. Cell. Endocrinol.
123,
61-69
9.
Gupta, C.,
Chandorkar, A.,
and Nguyen, A. P.
(1996)
Mol. Cell. Endocrinol.
123,
89-95
10.
Rich, K. A.,
Bardin, C. W.,
Gunsalus, G. L.,
and Mather, J. P.
(1983)
Endocrinology
113,
2284-2293
11.
Verhoeven, G.,
and Cailleau, J.
(1986)
Mol. Cell. Endocrinol.
47,
99-106
12.
Radhakrishnan, B.,
Oke, B. O.,
Papadopoulos, V.,
DiAugustine, R. P.,
and Suarez-Quian, C. A.
(1992)
Endocrinology
131,
3091-3099
13.
Kwan, R. W. P.,
Wong, R. W. C.,
and Chan, S. Y.
(1999)
Int. J. Oncol.
15,
281-284
14.
Zhang, M.,
Kim, H. J.,
Marshall, H.,
Gendron-Maguire, M.,
Lucas, D. A.,
Baron, A.,
Gudas, L. J.,
Gridley, T.,
Krumlauf, R.,
and Grippo, J. F.
(1994)
Development
120,
2431-2442
15.
Hogan, B.,
Beddington, R.,
Constantini, F.,
and Lacy, E.
(1994)
Manipulating the Mouse Embryo
, pp. 232-248, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
16.
Wong, R. W. C., Sham, M. H., Lau, Y. L., and Chan,
S. Y. (2000) Mol. Biotechnol., in press
17.
Wong, R. W. C., and Chan, S. Y. (2000) Mol.
Biotechnol., in press
18.
Lee, D. C. W.,
Chan, K. W.,
and Chan, S. Y.
(1998)
J. Urol.
159,
291-296
19.
Hoath, S. B.
(1986)
Pediat. Res.
20,
468-472
20.
Calamandrei, G.,
and Alleva, E.
(1989)
Brain Res.
477,
1-6
21.
Webber, E. M.,
Wu, J. C.,
Wang, L.,
Merlino, G.,
and Fausto, N.
(1994)
Amer. J. Pathol.
145,
398-408
22.
Dealy, C. N.,
Scranton, V.,
and Cheng, H. C.
(1998)
Dev. Biol.
202,
43-55
23.
Erwin, C. R.,
Helmrath, M. A.,
Shin, C. E.,
Falcone, R. A., Jr,
Stern, L. E.,
and Warner, B. W.
(1999)
Am. J. Physiol.
277,
G533-G540
24.
Noguchi, S.,
Ohba, Y.,
and Oka, T.
(1990)
Endocrinology
127,
2136-2140
25.
Colgan, T. J.,
Bedard, Y. C.,
Strawbridge, T. G.,
Bubkspan, M. B.,
and Klotz, P. G.
(1980)
Fertil. Steril.
33,
56-60
26.
Meyer, J. M.,
Maetz, J. L.,
and Rumpler, Y.
(1992)
Histopathology
21,
25-33
27.
Moghal, N.,
and Sternberg, P. W.
(1999)
Curr. Opin. Cell Biol.
11,
190-196
28.
Bartlett, J. M. S.,
Spiteri-Grech, J.,
and Nieschlag, E.
(1990)
Endocrinology
127,
747-758
29.
Haneji, T.,
Koide, S.,
Tajima, Y.,
and Nishimune, Y.
(1991)
J. Endocrinol.
128,
383-388
30.
Damjanov, I.,
Solter, D.,
and Knowles, B. B.
(1993)
Biochem. Biophys. Res. Commun.
190,
901-906
31.
Luetteke, N. C.,
Qiu, T. H.,
Fenton, S. E.,
Troyer, K. L.,
Riedel, R. F.,
Chang, A.,
and Lee, D. C.
(1999)
Development
126,
2739-2750
32.
Riese II, D. J.,
and Stern, D. F.
(1998)
Bioessays
20,
41-48
33.
Welsh, T. H.,
and Hsueh, A. J. W.
(1982)
Endocrinology
110,
1498-1506
34.
Yan, Y. C.,
Sun, Y. P.,
and Zhang, M. L.
(1998)
Arch. Androl.
40,
133-146
35.
Brooks, D. E.
(1979)
J. Endocrinol.
82,
293-303
36.
Shima, H.,
Tsuji, M.,
Young, P.,
and Cunha, G. R.
(1990)
Endocrinology
127,
3222-3233
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. R. Schneider, M. Dahlhoff, N. Herbach, I. Renner-Mueller, C. Dalke, O. Puk, J. Graw, R. Wanke, and E. Wolf Betacellulin Overexpression in Transgenic Mice Causes Disproportionate Growth, Pulmonary Hemorrhage Syndrome, and Complex Eye Pathology Endocrinology, December 1, 2005; 146(12): 5237 - 5246. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Fritz, M. S. Cotroneo, J. Wang, I.-E. Eltoum, and C. A. Lamartiniere Dietary Diethylstilbestrol but Not Genistein Adversely Affects Rat Testicular Development J. Nutr., July 1, 2003; 133(7): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W.-C. Wong, M. Setou, J. Teng, Y. Takei, and N. Hirokawa Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice PNAS, October 29, 2002; 99(22): 14500 - 14505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. Lei, S. Mishra, W. Zou, B. Xu, M. Foltz, X. Li, and Ch. V. Rao Targeted Disruption of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Gene Mol. Endocrinol., January 1, 2001; 15(1): 184 - 200. [Abstract] [Full Text] |
||||
![]() |
S.-Y. Chan and R. W.-C. Wong Expression of Epidermal Growth Factor in Transgenic Mice Causes Growth Retardation J. Biol. Chem., December 1, 2000; 275(49): 38693 - 38698. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |